Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma

BACKGROUND: Bmi1 (B lymphoma Mo-MLV insertion region 1 homolog) contributes to human tumorigenesis via epigenetic transcriptional silencing and represents a novel therapeutic target with great potentials. Here we sought to determine the therapeutic efficiency of PTC-209, a potent and selective Bmi1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiong, Li, Zhongwu, Wu, Yaping, Huang, Rong, Zhu, Yumin, Zhang, Wei, Wang, Yanling, Cheng, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697105/
https://www.ncbi.nlm.nih.gov/pubmed/29200967
http://dx.doi.org/10.1186/s12935-017-0481-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697105/
https://www.ncbi.nlm.nih.gov/pubmed/29200967
http://dx.doi.org/10.1186/s12935-017-0481-z

Ejemplares similares